# Vascular Dysfunction and Antiangiogenic Therapy

> **NCT02161978** · — · COMPLETED · sponsor: **University Hospital, Angers** · enrollment: 93 (actual)

## Conditions studied

- Solid Tumor
- Tumor Angiogenesis
- Endothelial Dysfunction
- CML (Chronic Myelogenous Leukemia)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02161978
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-09
- **Primary completion:** 2018-12-12
- **Final completion:** 2018-12-12
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2019-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02161978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02161978, "Vascular Dysfunction and Antiangiogenic Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02161978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*